Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Headwall Photonics is a private applied sensing and photonics company that designs and manufactures hyperspectral imaging systems, spectral instrumentation, optical components, and related software. The company serves industrial inspection, remote sensing, environmental monitoring, food quality and safety, recycling, defense and security, research, and some pharmaceutical quality-control applications rather than developing therapeutics. Its offerings span hyperspectral cameras, airborne payloads, OEM optical modules, diffraction gratings, and software used to capture, analyze, and operationalize spectral data. Since Arsenal Capital Partners became majority owner in 2022, Headwall has expanded through acquisitions and strategic investments including perClass, Holographix, inno-spec, and EVK. The company positions itself as a commercial-stage platform for turning spectral and molecular imaging data into actionable insight across science and industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Headwall Photonics.